
Our clinical webinar series is a trusted education resource for primary healthcare professionals, delivering practical, evidence-based insights to support the prevention, diagnosis and management of cardiovascular disease (CVD).
Each session explores the latest research, clinical guidelines and real-world approaches you can apply in practice to improve patient outcomes. Accredited by the RACGP for the 2026–2028 triennium, the series provides free, evidence-based education that bridges clinical insights with practical application.
All current RACGP and ACRRM-accredited webinars are available in our free Health Professional Learning Hub, offering a flexible and convenient way to stay up to date with best practice in cardiovascular care.
You can view past clinical webinars from the last five years below. These recordings are no longer CPD-accredited but were originally delivered as part of our accredited live webinar series.
Presented by leading Australian and international experts, these on-demand webinars remain a valuable, evidence-based resource to support ongoing learning. They help primary care health professionals stay informed about key developments and advances in cardiovascular care.
Explore a range of topics and revisit important clinical updates from across the series.
For the latest live webinar replay and current CPD-accredited webinars, visit the Health Professional Learning Hub.

Poor diet is a leading risk factor of coronary heart disease, contributing to 50% of the total burden of heart disease. Furthermore, disease burden attributed to dietary risks is not distributed equally across Australia.

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in people living with chronic kidney disease (CKD). Even after adjusting for traditional risk factors, CVD is associated with an increased risk of all-cause and cardiovascular mortality.1 There is an independent inverse association between reduced estimated glomerular filtration rate (eGFR) and, albuminuria, and increased cardiovascular mortality.2,3

People with diabetes are up to four times more likely to have a heart attack or stroke, often regarded as the risk equivalent to someone who has previously had a heart attack or stroke.1,2 They also face cardiovascular disease (CVD) as the leading cause of death.3 Managing CVD risk in this group is undoubtedly critical.

Streamed live during Heart Week 2022, this webinar explores the latest evidence on the management of high cholesterol in the context of cardiovascular risk reduction. Panellists discuss new and emerging pharmacological strategies for lipid lowering and translate the latest evidence to support preventative CVD risk assessment and management.

Hypertension is responsible for the largest burden of cardiovascular disease (CVD) in Australia.1 Even with gradual improvements in awareness and management, a significant proportion of hypertensive adults still fail to achieve recommended blood pressure (BP) targets.2

High cholesterol contributes to over a third of coronary heart disease burden. Despite well-established evidence supporting the benefits of cholesterol lowering for the prevention of cardiovascular disease (CVD), many patients fail to meet their lipid targets.